Greenwich LifeSciences Stock (NASDAQ:GLSI), Quotes and News Summary

Q: What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.

Open	$13.130
Close	$12.620
Volume / Avg.	28.651K / 51.357K
Day Range	12.360 - 13.180
52 Wk Range	7.580 - 21.440
Market Cap	$154.541M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	2.3%
Days to Cover	4.02

Recent News

Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Avi Kapoor

Why Greenwich Lifesciences (GLSI) Stock Is Skyrocketing

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.

Henry Khederian

$4.7M Bet On Tilly's? Check Out These 3 Stocks Insiders Are Buying

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Greenwich LifeSciences Inc

Sector

Health Care

Industry

Biotechnology

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Greenwich LifeSciences (GLSI) stock?

You can purchase shares of Greenwich LifeSciences (NASDAQ: GLSI) through any online brokerage.

View our list of the best stock brokerages.

Who are Greenwich LifeSciences's (GLSI) competitors?

Other companies in Greenwich LifeSciences’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and Adicet Bio (NASDAQ:ACET).

What is the target price for Greenwich LifeSciences (GLSI) stock?

The latest price target for Greenwich LifeSciences (NASDAQ: GLSI) was reported by HC Wainwright & Co. on Wednesday, February 28, 2024. The analyst firm set a price target for 36.00 expecting GLSI to rise to within 12 months (a possible 200.00% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Greenwich LifeSciences (GLSI)?

The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $12 last updated April 22, 2024 at 4:11 PM EDT.

Does Greenwich LifeSciences (GLSI) pay a dividend?

There are no upcoming dividends for Greenwich LifeSciences.

When is Greenwich LifeSciences (NASDAQ:GLSI) reporting earnings?

Greenwich LifeSciences’s Q1 earnings are confirmed for Monday, May 20, 2024.

Is Greenwich LifeSciences (GLSI) going to split?

There is no upcoming split for Greenwich LifeSciences.

What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-